Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 25021-174

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 25021-174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Dap01 0017 01)

Chemical structure of daptomycin, the active ingredient shown in the image, depicting its molecular arrangement for the antibiotic injection product.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Dap01 0017 02)

Label for Daptomycin Injection 500 mg per vial, lyophilized powder for intravenous use only. Manufactured for Sagent Pharmaceuticals, made in India. The label includes storage instructions to refrigerate between 2° to 8°C (36° to 46°F) and states it is a single-dose vial with 10 mL of 0.9% sodium chloride for reconstitution. The NDC is 25021-174-15.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.